A detailed history of Deutsche Bank Ag\ transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 41,174 shares of SWTX stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,174
Previous 31,570 30.42%
Holding current value
$1.47 Million
Previous $1.19 Million 10.93%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$32.04 - $42.76 $307,712 - $410,667
9,604 Added 30.42%
41,174 $1.32 Million
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $132,268 - $174,670
-3,668 Reduced 10.41%
31,570 $1.19 Million
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $46,501 - $66,885
1,274 Added 3.75%
35,238 $1.73 Million
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $62,369 - $122,631
3,293 Added 10.74%
33,964 $1.24 Million
Q3 2023

Nov 09, 2023

SELL
$23.12 - $31.38 $1.04 Million - $1.41 Million
-44,994 Reduced 59.46%
30,671 $709,000
Q2 2023

Aug 14, 2023

BUY
$23.15 - $32.71 $462,467 - $653,447
19,977 Added 35.87%
75,665 $1.98 Million
Q1 2023

May 15, 2023

SELL
$24.97 - $34.05 $2.45 Million - $3.34 Million
-98,127 Reduced 63.8%
55,688 $1.43 Million
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $1.02 Million - $1.35 Million
46,891 Added 43.85%
153,815 $4 Million
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $9,326 - $15,348
-387 Reduced 0.36%
106,924 $3.05 Million
Q2 2022

Aug 11, 2022

BUY
$18.36 - $60.07 $41,713 - $136,479
2,272 Added 2.16%
107,311 $2.64 Million
Q1 2022

May 13, 2022

SELL
$48.97 - $65.46 $59,351 - $79,337
-1,212 Reduced 1.14%
105,039 $5.93 Million
Q4 2021

Feb 11, 2022

SELL
$53.3 - $75.84 $366,544 - $521,551
-6,877 Reduced 6.08%
106,251 $6.59 Million
Q3 2021

Nov 04, 2021

BUY
$62.66 - $88.26 $436,552 - $614,907
6,967 Added 6.56%
113,128 $7.18 Million
Q2 2021

Aug 11, 2021

BUY
$67.45 - $85.63 $2.61 Million - $3.31 Million
38,657 Added 57.27%
106,161 $8.75 Million
Q1 2021

May 13, 2021

BUY
$65.1 - $93.59 $3.16 Million - $4.55 Million
48,605 Added 257.18%
67,504 $4.97 Million
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $310,809 - $500,791
6,427 Added 51.53%
18,899 $1.37 Million
Q3 2020

Nov 12, 2020

BUY
$36.14 - $51.99 $63,389 - $91,190
1,754 Added 16.36%
12,472 $594,000
Q2 2020

Aug 13, 2020

BUY
$22.98 - $48.57 $162,951 - $344,409
7,091 Added 195.51%
10,718 $451,000
Q1 2020

May 14, 2020

SELL
$20.44 - $41.21 $4,292 - $8,654
-210 Reduced 5.47%
3,627 $98,000
Q4 2019

Feb 14, 2020

BUY
$17.74 - $39.52 $68,068 - $151,638
3,837 New
3,837 $147,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.24B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.